Thus, PD-1/CD80+ exosomes convert tumors to an immunologically cold phenotype through adaptive redistribution of PD-L1 in tumor cells, enabling tumor cells to shift PD-L1 expression to immune interaction sites, and thereby dampening cytotoxic T cell activation and promoting immune escape. The gene discussed is CD80; the disease is neoplasm.